美国IotaMotion获得了机器人耳植入系统的专利,帮助4岁以上的患者进行精确手术. IotaMotion gains U.S. patent for robotic cochlear implant system, aiding precise surgery for patients aged 4+.

以圣保罗为基地的一家医疗技术公司,Iotamotion已获得美国专利No. IotaMotion, a St. Paul-based medical tech company, has received U.S. Patent No. 12,558,123,加强其在机器人辅助耳垂植入手术中的知识产权。 12,558,123, strengthening its intellectual property in robotic-assisted cochlear implant surgery. 该专利涵盖经林业发展局批准的IotaSOFT插入系统中使用的机器人定位和控制系统,这是为四岁以上病人核准的第一种且是唯一一种此类装置。 The patent covers robotic positioning and control systems used in its FDA-cleared iotaSOFT® Insertion System, the first and only such device approved for patients aged four and older. 该技术使精确、有控制的电极插入能够保护微妙的内耳结构,目的是改善结果和扩大获得机会——目前全世界估计有6 000万合格者中有不到5%的人接受植入。 The technology enables precise, controlled electrode insertion to protect delicate inner ear structures, aiming to improve outcomes and expand access—fewer than 5% of the estimated 60 million eligible people worldwide currently receive implants. 该系统在美国商业上可供使用,在其他地方正在临床调查。 The system is commercially available in the U.S. and under clinical investigation elsewhere.